ArticleJHEP reports : innovation in hepatology2021

Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis.

Emma L Shepherd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.